· Manufacturing & Investment · Source: pharma.economictimes.indiatimes.com

Merck channels over ₹140 crore into Bengaluru manufacturing site expansion

Merck has expanded its life sciences manufacturing site in Jigani, Bengaluru, with an investment of about €13 million (~Rs 140 crore), adding biological buffer production to its existing chemistry capabilities. The move strengthens local supply for research, diagnostics and biopharma customers across India and Asia-Pacific, reducing import dependence and reinforcing Merck's "Make in India" commitments.

Read source

Evaluating a similar location, plant, or policy window?

Bucephalus advises on greenfield industrial projects in South India.

Talk to Bucephalus

This page is a curated briefing. The original article belongs to pharma.economictimes.indiatimes.com. Bucephalus does not republish the source in full.